NCT03813121View on ClinicalTrials.gov

The Effects of Sedatives on Tobacco Use Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Tobacco Use Disorder
Interventions
DRUG

midazolam intravenous infusion

Participants will receive a single drug infusion

DRUG

placebo intravenous infusion

Participants will receive a single placebo infusion

DRUG

ketamine intravenous infusion

Participants will receive a single drug infusion

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03813121 - The Effects of Sedatives on Tobacco Use Disorder | Biotech Hunter | Biotech Hunter